News - Strides Arcolab, Asia-Pacific


Popular Filters

Malaysian Bio-XCell and Agila Biotech join forces on biotech facility


In conjunction with Asia's leading biopharma industry gathering, the BioPharma Asia Convention (BioPharma…

Agila BiotechAsia-PacificBio-XCellBiotechnologyFinancialProductionStrides Arcolab

Eli Lilly in deal with Strides Arcolab for cancer drugs in emerging markets


US pharma major Eli Lilly (NYSE: LLY) and Indian drugmaker Strides Arcolab (BO: 532531) have entered…

Asia-PacificEli LillyGenericsLicensingMarkets & MarketingStrides Arcolab

Watson buys Strides Arcolab unit for A$375 million; 2011 results


US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has kicked off the new year with the acquisition…

Ascent PharmahealthAsia-PacificFinancialGenericsMergers & AcquisitionsStrides ArcolabWatson Pharmaceuticals

Back to top